Neurogen Corporation Announces Webcast of Fiscal 2007 Financial Results on March 17

BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (NASDAQ: NRGN), a drug discovery and development company, announced today that it will release its fiscal 2007 financial results on Monday, March 17, 2008 before the opening of the U.S. financial markets. The Company will host a conference call and live audio webcast that same day at 8:30 a.m. EDT to review the results.

The news release and live webcast may be accessed through the investor relations section of the Company's web site: www.neurogen.com. The webcast will be also be archived in this section, under "Events Calendar and Replays."

About Neurogen

Neurogen Corporation is a drug discovery and development company with clinical programs in insomnia, Parkinson’s disease, Restless Legs Syndrome (RLS), pain, anxiety, and schizophrenia. Neurogen focuses its small molecule drug discovery efforts on specialist care indications with great unmet medical need. Neurogen conducts its research and development independently and, when advantageous, collaborates with world-class pharmaceutical companies to access additional resources and expertise.